These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34746546)

  • 1. Noninvasive Tracking of Natural Killer Cells Using Gold Nanoparticles.
    Shamalov K; Meir R; Motiei M; Popovtzer R; Cohen CJ
    ACS Omega; 2021 Nov; 6(43):28507-28514. PubMed ID: 34746546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomedicine for Cancer Immunotherapy: Tracking Cancer-Specific T-Cells in Vivo with Gold Nanoparticles and CT Imaging.
    Meir R; Shamalov K; Betzer O; Motiei M; Horovitz-Fried M; Yehuda R; Popovtzer A; Popovtzer R; Cohen CJ
    ACS Nano; 2015 Jun; 9(6):6363-72. PubMed ID: 26039633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-Time Tracking of
    Uong TNT; Lee KH; Ahn SJ; Kim KW; Min JJ; Hyun H; Yoon MS
    Front Immunol; 2018; 9():825. PubMed ID: 29770131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Live cell imaging of highly activated natural killer cells against human hepatocellular carcinoma in vivo.
    Uong TNT; Yoon MS; Lee KH; Hyun H; Nam TK; Min JJ; Nguyen HPQ; Kim SK
    Cytotherapy; 2021 Sep; 23(9):799-809. PubMed ID: 34176769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectual Labeling of Natural Killer Cells with Upconverting Nanoparticles by Electroporation for In Vivo Tracking and Biodistribution Assessment.
    Park HS; Kim J; Cho MY; Cho YJ; Suh YD; Nam SH; Hong KS
    ACS Appl Mater Interfaces; 2020 Nov; 12(44):49362-49370. PubMed ID: 33050704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging.
    Daldrup-Link HE; Meier R; Rudelius M; Piontek G; Piert M; Metz S; Settles M; Uherek C; Wels W; Schlegel J; Rummeny EJ
    Eur Radiol; 2005 Jan; 15(1):4-13. PubMed ID: 15616814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and (111)In-Oxine Labeling of Murine NK Cells for Assessment of Cell Trafficking in Orthotopic Lung Tumor Model.
    Malviya G; Nayak T; Gerdes C; Dierckx RA; Signore A; de Vries EF
    Mol Pharm; 2016 Apr; 13(4):1329-38. PubMed ID: 26962716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design principles for noninvasive, longitudinal and quantitative cell tracking with nanoparticle-based CT imaging.
    Meir R; Betzer O; Motiei M; Kronfeld N; Brodie C; Popovtzer R
    Nanomedicine; 2017 Feb; 13(2):421-429. PubMed ID: 27720990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting and Therapy of Glioblastoma in a Mouse Model Using Exosomes Derived From Natural Killer Cells.
    Zhu L; Oh JM; Gangadaran P; Kalimuthu S; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
    Front Immunol; 2018; 9():824. PubMed ID: 29740437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of antitumor potency of extracellular vesicles derived from natural killer cells by IL-15 priming.
    Zhu L; Kalimuthu S; Oh JM; Gangadaran P; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
    Biomaterials; 2019 Jan; 190-191():38-50. PubMed ID: 30391801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cationic Nanoparticle-Mediated Activation of Natural Killer Cells for Effective Cancer Immunotherapy.
    Kim KS; Han JH; Choi SH; Jung HY; Park JD; An HJ; Kim SE; Kim DH; Doh J; Han DK; Kim IH; Park W; Park KS
    ACS Appl Mater Interfaces; 2020 Dec; 12(51):56731-56740. PubMed ID: 33290037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional nanoparticles for genetic engineering and bioimaging of natural killer (NK) cell therapeutics.
    Kim KS; Han JH; Park JH; Kim HK; Choi SH; Kim GR; Song H; An HJ; Han DK; Park W; Park KS
    Biomaterials; 2019 Nov; 221():119418. PubMed ID: 31419655
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Shevtsov M; Pitkin E; Ischenko A; Stangl S; Khachatryan W; Galibin O; Edmond S; Lobinger D; Multhoff G
    Front Immunol; 2019; 10():454. PubMed ID: 30967859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vivo Tracking of Cell Viability for Adoptive Natural Killer Cell-Based Immunotherapy by Ratiometric NIR-II Fluorescence Imaging.
    Liao N; Su L; Zheng Y; Zhao B; Wu M; Zhang D; Yang H; Liu X; Song J
    Angew Chem Int Ed Engl; 2021 Sep; 60(38):20888-20896. PubMed ID: 34268865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vivo Neuroimaging of Exosomes Using Gold Nanoparticles.
    Betzer O; Perets N; Angel A; Motiei M; Sadan T; Yadid G; Offen D; Popovtzer R
    ACS Nano; 2017 Nov; 11(11):10883-10893. PubMed ID: 28960957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid accumulation impairs natural killer cell cytotoxicity and tumor control in the postoperative period.
    Niavarani SR; Lawson C; Bakos O; Boudaud M; Batenchuk C; Rouleau S; Tai LH
    BMC Cancer; 2019 Aug; 19(1):823. PubMed ID: 31429730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Near-infrared emitting fluorescent nanocrystals-labeled natural killer cells as a platform technology for the optical imaging of immunotherapeutic cells-based cancer therapy.
    Lim YT; Cho MY; Noh YW; Chung JW; Chung BH
    Nanotechnology; 2009 Nov; 20(47):475102. PubMed ID: 19875875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cells generated from cord blood hematopoietic progenitor cells efficiently target bone marrow-residing human leukemia cells in NOD/SCID/IL2Rg(null) mice.
    Cany J; van der Waart AB; Tordoir M; Franssen GM; Hangalapura BN; de Vries J; Boerman O; Schaap N; van der Voort R; Spanholtz J; Dolstra H
    PLoS One; 2013; 8(6):e64384. PubMed ID: 23755121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Migration of iron-labeled KHYG-1 natural killer cells to subcutaneous tumors in nude mice, as detected by magnetic resonance imaging.
    Mallett CL; McFadden C; Chen Y; Foster PJ
    Cytotherapy; 2012 Jul; 14(6):743-51. PubMed ID: 22443465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tracking of [18F]FDG-labeled natural killer cells to HER2/neu-positive tumors.
    Meier R; Piert M; Piontek G; Rudelius M; Oostendorp RA; Senekowitsch-Schmidtke R; Henning TD; Wels WS; Uherek C; Rummeny EJ; Daldrup-Link HE
    Nucl Med Biol; 2008 Jul; 35(5):579-88. PubMed ID: 18589302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.